









Markets
/
Stocks
/
nasdaq-mxrx
/

Med X Units (Proposed)

MXRX

0.000

Close 12/19, 16:00（ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



Med X Units (Proposed)

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Med X Units (Proposed) to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2023Q1

FY2022Q2

FY2022Q1

FY2021Q2

Operating cash flows (indirect method)

Cash flow from continuing operating activities

28.48%-1.27M

-2.58%-1.04M

---1.78M

---1.02M

Net income from continuing operations

20.37%-1.13M

-247.65%-3.00M

---1.42M

---862.23K

Operating gains losses

45.55%10.18K

-40.13%9.11K

--6.99K

--15.21K

Other non-cash items

-83.33%1.80K

1127.09%1.89M

--10.78K

--153.87K

Change in working capital

59.15%-153.81K

117.34%56.00K

---376.56K

---323.04K

-Change in receivables

83.41%-17.84K

91.72%-9.78K

---107.51K

---118.05K

-Change in inventory

241.68%95.20K

112.78%9.79K

---67.20K

---76.66K

-Change in prepaid expenses

85.12%-21.93K

-18.31%-78.73K

---147.44K

---66.54K

-Change in payables and accrued expense

-285.54%-209.77K

318.01%134.72K

---54.41K

---61.79K

Cash from non-recurring investing activities

Cash from operating activities

28.48%-1.27M

-2.58%-1.04M

---1.78M

---1.02M

Investing cash flow

Net cash from continuing investing activities

----

73.09%-9.69K

--58.40K

---36.00K

Capital expenditures

----

--58.40K

----

Net cash flow from disposal of fixed assets

----

73.09%-9.69K

--58.40K

---36.00K

Cash from non-current investing activities

Net cash flow from investing activities

----

-73.09%9.69K

---58.40K

--36.00K

Financing cash flow

Cash flow from continuous financing activities

12.30%1.27M

-47.26%843.94K

--1.13M

--1.60M

Net cash flow from debt Issuance/repayment

-105.14%-3.95K

-80.00%15.07K

--76.91K

--75.37K

Net cash flow from common stock issuance/repurchase

20.87%1.27M

-45.64%828.87K

--1.05M

--1.52M

Net cash from non-recurrent financing activities

Net cash from financing activities

12.30%1.27M

-47.26%843.94K

--1.13M

--1.60M

Net cash flow

Beginning cash balance

-84.68%209.47K

17.18%662.16K

--1.37M

--565.08K

Current period cash flow changes

99.82%-1.26K

-130.46%-188.79K

---705.21K

--619.87K

Ending cash balance

-68.56%208.21K

-60.05%473.38K

--662.16K

--1.18M

Free cash flow

----

-2.58%-1.04M

---1.84M

---1.02M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

